In vivo PET of synaptic density as potential diagnostic marker for cognitive disorders: prospective comparison with current imaging markers for neuronal dysfunction and relation to symptomatology - study protocol

Abstract Background 18F-FDG brain PET is clinically used for differential diagnosis in cognitive dysfunction of unclear etiology and for exclusion of a neurodegenerative cause in patients with cognitive impairment in late-life psychiatric disorders. 18F-FDG PET measures regional glucose metabolism,...

Full description

Bibliographic Details
Published in:BMC Medical Imaging
Main Authors: Greet Vanderlinden, Charles Carron, Rik Vandenberghe, Mathieu Vandenbulcke, Koen Van Laere
Format: Article
Language:English
Published: BMC 2024-02-01
Subjects:
Synaptic density
18F-SynVesT-1
Glucose metabolism
18F-FDG
PET-MR
Cognitive impairment
Online Access:https://doi.org/10.1186/s12880-024-01224-5

Internet

https://doi.org/10.1186/s12880-024-01224-5

Similar Items